Emerging biomarkers (including sST2, secretoneurin, PSP, and MR-proADM) offer insight into specific pathogenic axes such as inflammation, myocardial stress, endothelial dysfunction, and immune activation. The gene discussed is SCG2; the disease is endothelial dysfunction.